Inspiration Biopharmaceuticals Finds CEO
, a developer of treatments for hemophilia, announced today that it has appointed John P. Butler as its new CEO. Butler replaces current CEO Michael Griffith, who becomes Chief Scientific Officer and President. Butler was most recently at Genzyme Corporation, and has served at Amgen and Hoffmann-La Roche.
posted on Tuesday, October 11, 2011
> Inspiration Biopharmaceuticals Raises Funding To $247M
> Oblong Finds $15M More
> KYTHERA Biopharmaceuticals Names Chief Commercial Officer
> Sienna Biopharmaceuticals Files For IPO
> Imagine Finds $3.7M